Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 6/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.32 |
| ▸ | CASP6 | P55212 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23987675 | 0.83 | CYP1A2 (0.35) | CHRNB4CHRNA3 | |
| SCHEMBL21782074 | 0.74 | PPID (0.40) | — | |
| SCHEMBL21781817 | 0.72 | ITGB1 (0.41) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL22728411 | 0.71 | HTT (0.34) | — | |
| SCHEMBL14064141 | 0.71 | CHRNB4 (0.46) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL21781844 | 0.71 | MMP2 (0.42) | — | |
| SCHEMBL12323684 | 0.71 | CHRNB4 (0.42) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL22600820 | 0.70 | NPC1 (0.44) | CHRNB4CHRNA3 | |
| SCHEMBL18473157 | 0.70 | CHRNB4 (0.43) | CHRNB4CHRNA3 | |
| SCHEMBL2734906 | 0.70 | CHRNB4 (0.43) | CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023196824-A1 | ANTI-TUMOR ANTIBODIES | ATRECA, INC. (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023141517-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES | EXELIXIS, INC. (US) | 2023-07-27 | — | — | WO | disclosed |